Sponsor pipeline

Genelux Corporation clinical trial pipeline

Get alerts when Genelux Corporation's trials change

2 active trials 2 recruiting 1 Phase 3 3 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 2
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05281471 Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's… Platinum-resistant Ovarian Cancer Recruiting 2026-08-26
Phase 2
NCT06463665 Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice… Advanced Non-squamous Non-small-cell Lung Cancer Recruiting 2026-06-04

Disease areas by active trials

Ovarian Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Lung Cancer (1)

Get alerts when Genelux Corporation's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free